Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 46% ± 22% | |
lung | 11 studies | 25% ± 9% | |
peripheral blood | 10 studies | 23% ± 7% | |
eye | 8 studies | 36% ± 18% | |
heart | 5 studies | 30% ± 10% | |
liver | 5 studies | 31% ± 17% | |
bone marrow | 4 studies | 23% ± 10% | |
intestine | 4 studies | 22% ± 6% | |
adipose | 4 studies | 35% ± 10% | |
kidney | 4 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5613.86 | 1445 / 1445 | 100% | 23.31 | 183 / 183 |
prostate | 100% | 6915.45 | 245 / 245 | 100% | 29.31 | 502 / 502 |
breast | 100% | 6689.48 | 459 / 459 | 100% | 29.16 | 1117 / 1118 |
lung | 100% | 5585.08 | 578 / 578 | 100% | 20.77 | 1153 / 1155 |
brain | 100% | 3890.82 | 2636 / 2642 | 100% | 23.66 | 705 / 705 |
thymus | 100% | 8005.81 | 653 / 653 | 100% | 28.66 | 603 / 605 |
ovary | 100% | 8312.51 | 180 / 180 | 100% | 15.49 | 428 / 430 |
uterus | 100% | 7983.05 | 170 / 170 | 99% | 19.56 | 456 / 459 |
bladder | 100% | 6802.76 | 21 / 21 | 99% | 18.18 | 499 / 504 |
pancreas | 100% | 3347.82 | 328 / 328 | 99% | 18.08 | 176 / 178 |
intestine | 100% | 6537.82 | 966 / 966 | 98% | 18.49 | 518 / 527 |
stomach | 100% | 4465.91 | 359 / 359 | 98% | 19.19 | 280 / 286 |
adrenal gland | 100% | 4939.54 | 258 / 258 | 98% | 17.44 | 225 / 230 |
kidney | 100% | 4812.66 | 89 / 89 | 97% | 18.07 | 876 / 901 |
skin | 100% | 5479.43 | 1809 / 1809 | 92% | 17.79 | 434 / 472 |
liver | 100% | 2410.40 | 226 / 226 | 88% | 9.44 | 358 / 406 |
adipose | 100% | 6271.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7288.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3675.79 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5893.65 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.12 | 1 / 1 |
heart | 97% | 3068.85 | 834 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 13.14 | 28 / 29 |
peripheral blood | 73% | 2437.82 | 678 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 9.46 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070646 | Biological process | protein modification by small protein removal |
GO_0016925 | Biological process | protein sumoylation |
GO_0016926 | Biological process | protein desumoylation |
GO_0090169 | Biological process | regulation of spindle assembly |
GO_0090234 | Biological process | regulation of kinetochore assembly |
GO_0006508 | Biological process | proteolysis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070139 | Molecular function | SUMO-specific endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SENP6 |
Protein name | SUMO specific peptidase 6 Alternative protein SENP6 Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) |
Synonyms | FKSG6 SUSP1 SSP1 KIAA0797 |
Description | FUNCTION: Protease that deconjugates SUMO1, SUMO2 and SUMO3 from targeted proteins. Processes preferentially poly-SUMO2 and poly-SUMO3 chains, but does not efficiently process SUMO1, SUMO2 and SUMO3 precursors. Deconjugates SUMO1 from RXRA, leading to transcriptional activation. Involved in chromosome alignment and spindle assembly, by regulating the kinetochore CENPH-CENPI-CENPK complex. Desumoylates PML and CENPI, protecting them from degradation by the ubiquitin ligase RNF4, which targets polysumoylated proteins for proteasomal degradation. Desumoylates also RPA1, thus preventing recruitment of RAD51 to the DNA damage foci to initiate DNA repair through homologous recombination. . |
Accessions | H0Y8Y8 L8E9U8 D6RG09 ENST00000503501.1 L8ECG3 ENST00000447266.7 [Q9GZR1-1] D6RJH1 ENST00000424947.6 ENST00000370010.6 [Q9GZR1-2] H0Y4F4 ENST00000483859.6 ENST00000493959.6 Q9GZR1 ENST00000327284.12 F8W6D9 |